These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4072899)

  • 21. Fatal typhlitis secondary to procainamide-induced agranulocytosis.
    Clary RM; Beazley WS; Henley RW
    Va Med; 1984 Nov; 111(11):697-8. PubMed ID: 6506849
    [No Abstract]   [Full Text] [Related]  

  • 22. Agranulocytosis due to new sustained-release procainamide.
    Berger BE; Hauser DJ
    Am Heart J; 1983 Jun; 105(6):1035-6. PubMed ID: 6858823
    [No Abstract]   [Full Text] [Related]  

  • 23. Procainamide-induced agranulocytosis differs serologically and clinically from procainamide-induced lupus.
    Starkebaum G; Kenyon CM; Simrell CR; Creamer JI; Rubin RL
    Clin Immunol Immunopathol; 1996 Feb; 78(2):112-9. PubMed ID: 8625553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-myeloid-cell antibody in procainamide-induced agranulocytosis.
    Azócar J
    Lancet; 1984 May; 1(8385):1069-70. PubMed ID: 6143992
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversible procainamide-induced agranulocytosis twice in one patient.
    Konttinen YP; Tuominen L
    Lancet; 1971 Oct; 2(7730):925. PubMed ID: 4106683
    [No Abstract]   [Full Text] [Related]  

  • 26. Procainamide-induced agranulocytosis: report of two cases and review.
    Nagesh KG; Poulose KP; Tseng TH; Schadchehr A
    J Kans Med Soc; 1980 Jan; 81(1):18-24. PubMed ID: 6153211
    [No Abstract]   [Full Text] [Related]  

  • 27. Septic complications of procainamide-induced agranulocytosis: report of two cases.
    Freed JS; Reiner MA
    Mt Sinai J Med; 1988 Mar; 55(2):194-7. PubMed ID: 3290673
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversible severe anaemia and granulocytopenia caused by procainamide. A case report.
    van Beek RJ; Bieger R; den Ottolander GJ
    Scand J Haematol; 1978 Aug; 21(2):150-2. PubMed ID: 694426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agranulocytosis during combined procainamide and phenytoin therapy.
    Crook JE; Woosley RL; Leftwich RB; Natelson EA
    South Med J; 1979 Dec; 72(12):1599-601. PubMed ID: 515773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agranulocytosis caused by procainamide.
    Hickson B; Davidson RJ; Walker W
    Scott Med J; 1972 May; 17(5):165-8. PubMed ID: 4537437
    [No Abstract]   [Full Text] [Related]  

  • 31. Procainamide reactions.
    Chelius CJ; Nunag AN
    Wis Med J; 1975 Jan; 74(1):S1-6. PubMed ID: 1114849
    [No Abstract]   [Full Text] [Related]  

  • 32. [Procaine amide-induced agranulocytosis].
    Tuominen L; Konttinen YP
    Duodecim; 1972; 88(10):717-20. PubMed ID: 5068887
    [No Abstract]   [Full Text] [Related]  

  • 33. Desensitization to procainamide.
    Ream CR; Barrera R
    J Med Soc N J; 1970 Mar; 67(3):107-10. PubMed ID: 5264623
    [No Abstract]   [Full Text] [Related]  

  • 34. Necrotizing epiglottitis in a patient with procainamide-induced neutropenia.
    Goldsmith AJ; Schaeffer BT
    Am J Otolaryngol; 1994; 15(1):58-62. PubMed ID: 7510934
    [No Abstract]   [Full Text] [Related]  

  • 35. Agranulocytosis and lupus erythematosus phenomenon after procaine amide.
    Oster ZH
    Isr J Med Sci; 1966; 2(3):354-5. PubMed ID: 5956231
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe transient pancytopenia associated with procainamide ingestion.
    Bluming AZ; Plotkin D; Rosen P; Thiessen AR
    JAMA; 1976 Nov; 236(22):2520-1. PubMed ID: 1036516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine-Associated Neutropenia and Agranulocytosis.
    Andres E; Mourot-Cottet R
    J Clin Psychopharmacol; 2017 Dec; 37(6):749-750. PubMed ID: 29040154
    [No Abstract]   [Full Text] [Related]  

  • 38. Clozapine, agranulocytosis, and benign ethnic neutropenia.
    Rajagopal S
    Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
    [No Abstract]   [Full Text] [Related]  

  • 39. Administration of filgrastim in two patients with drug-induced agranulocytosis.
    Castanheira D; Marzella M; Skirvin JA
    Pharmacotherapy; 1998; 18(6):1347-51. PubMed ID: 9855337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents].
    Knipping W
    Med Klin; 1980 Feb; 75(3):108-15. PubMed ID: 7374607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.